Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
- DOI
- 10.1067/mai.2001.117880
- Published
- 2001 Aug
- Container
- The Journal of allergy and clinical immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1067/mai.2001.117880,
title = {Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.},
author = {Busse W and Corren J and Lanier BQ and McAlary M and Fowler-Taylor A and Cioppa GD and van As A and Gupta N},
year = {2001},
journal = {The Journal of allergy and clinical immunology},
doi = {10.1067/mai.2001.117880},
url = {https://doi.org/10.1067/mai.2001.117880}
}RIS
TY - JOUR TI - Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. AU - Busse W AU - Corren J AU - Lanier BQ AU - McAlary M AU - Fowler-Taylor A AU - Cioppa GD AU - van As A AU - Gupta N PY - 2001 JO - The Journal of allergy and clinical immunology DO - 10.1067/mai.2001.117880 UR - https://doi.org/10.1067/mai.2001.117880 ER -
APA
W, B., J, C., BQ, L., M, M., A, F., GD, C., A, V. A., & N, G. (2001). Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.. The Journal of allergy and clinical immunology. https://doi.org/10.1067/mai.2001.117880
Source records
- pubmed · retrieved 2026-11-10T11:37:27.778Z